Stage III Mesothelioma
2 clinical trials · Condition
◉ Watch Stage III Mesothelioma
| Record | Firm | Date |
|---|---|---|
| Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT02567396) | National Cancer Institute (NCI) | 2016-06-01 |
| 18F-FSPG PET/CT for Cancer Patients on Therapy (NCT02599194) | Andrei Iagaru | 2015-07-01 |
Track Stage III Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.